Archives
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2018-07
-
Cytoskeleton-Dependent Autophagy Under Mechanical Stress
2026-05-21
This study demonstrates that mechanical stress-induced autophagy in human cells critically depends on cytoskeletal microfilaments, with microtubules playing a supportive role. These findings clarify the mechanotransduction pathway, informing future experimental approaches in cell signaling and cancer research.
-
Epalrestat: Expanding Neuroprotection Beyond Diabetic Models
2026-05-21
Explore Epalrestat as an advanced aldose reductase inhibitor for oxidative stress research and neurodegenerative disease models. This article delivers a unique, in-depth analysis of KEAP1/Nrf2 pathway activation and practical assay considerations.
-
AG-221 (Enasidenib): Systems Biology Insights for IDH2-Mutan
2026-05-20
Explore how AG-221 (Enasidenib) enables integrated, systems-level research on IDH2-mutant acute myeloid leukemia. This article offers original analysis on metabolic rewiring, resistance, and practical assay design—distinguishing it from existing protocol-centric guides.
-
SM-102: Optimizing mRNA Delivery with Advanced Lipid Nanopar
2026-05-20
SM-102 stands out as a high-purity ionizable lipid engineered to enhance mRNA vaccine delivery through lipid nanoparticles. This guide walks researchers through real-world protocol improvements, data-driven comparative insights, and actionable troubleshooting to unlock reproducible, high-efficiency mRNA delivery for both vaccine and therapeutic applications.
-
Spiroplasma eriocheiris Entry Mechanisms in Drosophila S2 Ce
2026-05-19
Wei et al. provide the first detailed characterization of how Spiroplasma eriocheiris invades Drosophila Schneider 2 (S2) cells, identifying clathrin-mediated endocytosis and macropinocytosis as key entry pathways. This work clarifies infection processes in invertebrate cell models and offers mechanistic insights relevant for infectious disease and cell biology research.
-
BMX-IN-1: Redefining BMX Kinase Inhibition in Lysosomal Biol
2026-05-19
Explore how BMX-IN-1, a potent BMX kinase inhibitor, is driving new frontiers in lysosomal acidification research and host-pathogen interactions. This article delivers advanced insights and unique protocol considerations for cancer and infectious disease modeling.
-
Wallichinine Reverses ABCB1-Mediated Multidrug Resistance in
2026-05-18
This study demonstrates that wallichinine, a natural compound from Piper wallichii, effectively reverses multidrug resistance (MDR) in cancer cells overexpressing the ABCB1 transporter. The findings provide mechanistic insight into how wallichinine restores chemosensitivity and offer a new direction for developing non-toxic MDR modulators from natural products.
-
Metronidazole: Applied OAT3 Inhibition in Microbiota Researc
2026-05-18
Metronidazole (2-(2-methyl-5-nitroimidazol-1-yl)ethanol) stands apart as both a nitroimidazole antibiotic and a precise OAT3 inhibitor, enabling advanced research in drug-drug interactions and microbiota-immune modulation. This article delivers actionable workflows, troubleshooting strategies, and data-driven insights for maximizing the impact of Metronidazole in bench-based studies.
-
EDI3 Inhibition Reduces Viability in HER2+ Breast Cancer Res
2026-05-17
Keller et al. demonstrate that targeting EDI3, a key enzyme in choline metabolism, preferentially reduces viability and tumor growth in ER-HER2+ breast cancer cells resistant to HER2-targeted therapies. Their study uncovers EDI3 as a metabolic vulnerability and potential therapeutic target in this difficult-to-treat cancer subtype.
-
Ferroptotic Tumor Cells Enhance Macrophage Antigen Presentat
2026-05-16
Sun et al. reveal that inducing ferroptosis in tumor cells reprograms tumor-associated macrophages to boost antigen presentation, thereby amplifying the efficacy of immune checkpoint blockade therapy. By delineating the mechanistic link between ferroptosis and adaptive anti-tumor immunity, this work provides a preclinical rationale for leveraging ferroptosis inducers to potentiate cancer immunotherapy.
-
YTHDF2 Inhibition Enhances Memory via m6A mRNA Stabilization
2026-05-15
This study demonstrates that conditional knockout of YTHDF2 in the mouse forebrain leads to reduced degradation of m6A-modified mRNAs, resulting in increased synaptic transmission and enhanced hippocampus-dependent memory. The findings clarify the mechanistic role of YTHDF2-mediated mRNA decay in activity-dependent protein synthesis and cognitive function, with significant implications for neuroepigenetic research.
-
Streamlining Macrolide Antibiotic Production via 3-O-Acyltra
2026-05-15
This study demonstrates the targeted genetic modification of Streptomyces spiramyceticus to produce a single-component macrolide antibiotic, 400-isovalerylspiramycin I, by in-frame partial deletion of the 3-O-acyltransferase gene. The approach addresses complexity in macrolide production, offering a path toward improved antibiotic manufacturing and specificity.
-
Ionomycin Calcium Salt: Unleashing Calcium Ionophore Potenti
2026-05-14
Ionomycin calcium salt stands apart as a precise and potent calcium ionophore for dissecting intracellular Ca2+ dynamics, apoptosis induction, and tumor inhibition. This article delivers actionable protocols, troubleshooting advice, and context from the latest research—empowering scientists to harness Ionomycin in advanced cell signaling and cancer studies.
-
Stiripentol: Applied Workflows for LDH Inhibition in Researc
2026-05-14
Stiripentol stands out as a noncompetitive LDH inhibitor, enabling precise modulation of lactate metabolism in epilepsy and immunometabolic studies. This guide translates recent mechanistic breakthroughs into actionable protocols, troubleshooting tactics, and advanced experimental strategies.
-
Annexin V-PE Apoptosis Detection Kit: Rapid Live-Cell Analys
2026-05-13
Experience swift, fixation-free apoptosis detection in live cells with the Annexin V-PE Apoptosis Detection Kit. This workflow-ready solution empowers researchers to quantify early apoptotic events with precision, streamlining both flow cytometry and fluorescence microscopy assays.